Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.3200
-0.0100 (-3.03%)
At close: Apr 2, 2026, 4:00 PM EDT
0.3296
+0.0096 (3.00%)
After-hours: Apr 2, 2026, 7:23 PM EDT
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $51.08 million as of April 2, 2026. Its market cap has decreased by -87.22% in one year.
Market Cap
51.08M
Enterprise Value
10.29M
1-Year Change
-87.22%
Ranking
Category
Stock Price
$0.32
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from $124.83M to $51.08M, a decrease of -59.08%. That is a compound annual growth rate of -12.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 51.08M | -22.97% |
| Dec 31, 2025 | 66.31M | -87.77% |
| Dec 31, 2024 | 542.14M | 67.64% |
| Dec 29, 2023 | 323.39M | 269.38% |
| Dec 30, 2022 | 87.55M | -49.64% |
| Dec 31, 2021 | 173.85M | -28.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kezar Life Sciences | 54.55M |
| Instil Bio | 54.46M |
| OS Therapies | 53.77M |
| NovaBay Pharmaceuticals | 51.92M |
| Radiopharm Theranostics | 51.41M |
| Edesa Biotech | 51.26M |
| Metagenomi Therapeutics | 50.79M |
| MiNK Therapeutics | 50.18M |